The CCR7/CCL19 signaling pathway is an important signaling pathway present in psoriasis, and studies demonstrate that inhibiting TNF leads to suppression of this pathway, resulting in dispersal of lymphoid clusters marked by the activation of this pathway, leading to amelioration of psoriasis symptoms (42, 43). The gene discussed is TNF; the disease is psoriasis.